A pharmaceutical company dedicated to improving health through the development.

, , a pharmaceutical company dedicated to improving health through the development, produce and commercialization of a wide selection of prescription and over the counter items, today announced that the Company’s Zhibai Dihuang Tablet and Ciwujia Tablet have already been approved on the market as traditional Chinese medicine in Hong Kong by Chinese Medication Council of Hong Kong, . Related StoriesSurvey displays most males with advanced prostate cancer ignore their symptoms as disease progressesAdvances in thoracic operation: an interview with Dan Wildman, VP Global Franchise Technique & Invention – EthiconUsing technology to protect diabetics from feet amputations: an interview with Heleen Kist, HCi ViocareGuangxi Lingfeng Pharmaceutical, , a wholly possessed subsidiary of AOBO, is the manufacturer of ZD Pill, which is formulated with pure 100 percent natural ingredients and herbs entirely.DTB says that bevacizumab might provide a lower cost alternate, but cautions that there surely is up to now no robust evidence of its safety and effectiveness in the treatment of macular degeneration. ‘As a result, we cannot recommend such use beyond clinical trials.’.. Aeras, CHC collaborate in Cambodian tuberculosis prevalence study Study to sign up up to at least one 1,000 infants and childrenThe Aeras Global TB Vaccine Base and the Cambodian Health Committee today announce the initiation of a study of tuberculosis prevalence in Svay Rieng Province, Cambodia, beginning this month.